Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA

ConclusionsCombining PRM and DIA measurements provides a new strategy for the sensitive and reproducible detection of protein markers from patients currently being discussed in molecular tumor boards in combination with the opportunity to discover new biomarker candidates.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research